PROCALCITONIN AT INFLAMMATORY DISEASES
Abstract
The research objective was to determine procalcitonin level at patients with inflammatory diseases with previous antibacterial therapy. 118 patients were examined. Before hospitalization to RSBHE Regional clinical hospital all patients were carried out antibacterial therapy in other medical organizations. Procalcitonin at entering at community-acquired pneumonia was 2,1 ± 0,98 ng/ml, at pneumogene sepsis - 3,7 ± 2,01 ng/ml, at abdominal sepsis - 18,4 ± 6,31 ng/ml, at other inflammatory diseases - 24,7 ± 11,63 ng/ml. It is expedient to consider procalcitonin level at inflammatory diseases.
About the Authors
E. A. Titova
SBEI HPE «Altai State Medical University of Ministry of Health»
Russian Federation
Russian Federation
Z. A. Titova
SBEI HPE «Altai State Medical University of Ministry of Health»
Russian Federation
Russian Federation
References
1. Зайцев А. А. Биологические маркеры воспаления при внебольничной пневмонии / А. А. Зайцев, Ю. В. Овчинников, Т. В. Кондратьева // Consilium Medicum. - 2014. - № 11. - С. 36-41.
2. Чучалин А. Г. Биологические маркеры при респираторных заболеваниях / А. Г. Чучалин // Терапевт. арх. - 2014. - № 3. - С. 4-13.
3. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections : the ProHOSP randomized controlled trial / P. Schuetz [et al.] // JAMA. - 2009. - Vol. 302, N 10. - P. 1059-1066.
4. Интерпретация значений концентрации прокальцитонина при инфекционных воспалительных процессах / И. А. Пятницкий [и др.] // Терапевт. арх. - 2012. - № 12. - С. 120-124.
5. Procalcitonin and C-Reactive protein hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD / М. Bafadhel [et al.] // Chest. - 2011. - Vol. 139, N 6. - P. 1410-1418.
Review
For citations:
Titova E.A., Titova Z.A. PROCALCITONIN AT INFLAMMATORY DISEASES. Journal of Siberian Medical Sciences. 2016;(1):2.
Views:
535
Email this article 